Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Deerfield Management Company, L.P. reported a 8.79% stake in Ars Pharmaceuticals, Inc. (Schedule 13D/A)
Event Jul 18, 2025 · Filed Jul 22, 2025
Deerfield Management Company, L.P. reported a 8.79% stake in Ars Pharmaceuticals, Inc., 8,633,537 shares, with active intent on Jul 18, 2025. Filed Jul 22, 2025 (Schedule 13D/A).
- Stake
- 8.79%
- Shares
- 8,633,537
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deerfield Mgmt III, L.P. | 4.40% | 4,316,768 |
| Deerfield Private Design Fund III, L.P. | 4.40% | 4,316,768 |
| Deerfield Mgmt IV, L.P. | 4.40% | 4,316,769 |
| Deerfield Private Design Fund IV, L.P. | 4.40% | 4,316,769 |
| Deerfield Management Company, L.P. | 8.79% | 8,633,537 |
| James E. Flynn | 8.79% | 8,633,537 |
Source
Related
- Ars Pharmaceuticals, Inc.
- Deerfield Management Company, L.P.
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Deerfield Management Company, L.P. · Aug 1, 2025
- Schedule 13D/A · Deerfield Management Company, L.P. · Jul 2, 2025
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 24, 2025
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026